HomeENTO • NASDAQ
add
Entero Therapeutics Inc
Previous close
$0.47
Day range
$0.41 - $0.48
Year range
$0.41 - $3.16
Market cap
2.08M USD
Avg Volume
267.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.89M | -44.87% |
Net income | -2.58M | 24.84% |
Net profit margin | — | — |
Earnings per share | -0.43 | 95.27% |
EBITDA | -1.89M | 44.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 366.79K | -88.86% |
Total assets | 85.82M | 1,347.89% |
Total liabilities | 15.77M | 495.46% |
Total equity | 70.05M | — |
Shares outstanding | 4.75M | — |
Price to book | 0.26 | — |
Return on assets | -5.50% | — |
Return on capital | -6.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.58M | 24.84% |
Cash from operations | -1.85M | 44.51% |
Cash from investing | 0.00 | — |
Cash from financing | 1.55M | -71.18% |
Net change in cash | -295.69K | -114.38% |
Free cash flow | -451.44K | 78.19% |
About
Founded
2014
Headquarters
Website
Employees
15
